9 February 2025
Helene Cooper, a New York Times correspondent who is participating in the Moderna vaccine trial, during an exam at George Washington University Hospital in Washington, Sept. 9, 2020. Cooper was invited to participate in the vaccine trial because of her multiple risk factors: she is a Black woman, a Type 1 diabetic and asthmatic. (Erin Schaff/The New York Times)

Helene Cooper, a New York Times correspondent who is participating in the Moderna vaccine trial, during an exam at George Washington University Hospital in Washington, Sept. 9, 2020. (Erin Schaff/The New York Times)

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.